Pulse Biosciences (PLSE) Cash from Operations (2015 - 2025)

Pulse Biosciences' Cash from Operations history runs 11 years deep, the most recent figure standing at 14755000.0 for Q4 2025.

• In Q4 2025, Cash from Operations fell 61.36% year-over-year to 14755000.0; the TTM figure through Dec 2025 stood at 54122000.0 (down 48.92% YoY), while the FY2025 annual figure was 54122000.0, down 48.92% from the prior year.
• Cash from Operations was 14755000.0 for Q4 2025 at Pulse Biosciences, down from 13039000.0 in the prior quarter.
• In the past five years, Cash from Operations ranged from a high of 6570000.0 in Q1 2023 to a low of 16366000.0 in Q2 2021.
• Historically, Cash from Operations has averaged 11230800.0 across 5 years, with a median of 11159500.0 in 2021.
• The sharpest annual moves came in 2021 and 2023: Cash from Operations plunged 106.15% in 2021, then surged 57.87% in 2023.
• A 5-year view of Cash from Operations shows it stood at 12694000.0 in 2021, then jumped by 37.25% to 7965000.0 in 2022, then increased by 14.85% to 6782000.0 in 2023, then sank by 34.83% to 9144000.0 in 2024, then slumped by 61.36% to 14755000.0 in 2025.
• The last three Cash from Operations figures came in at 14755000.0 (Q4 2025), 13039000.0 (Q3 2025), and 12807000.0 (Q2 2025), per Business Quant data.